» Articles » PMID: 15750083

Molecular Characterization of an Epidemic Clone of Panantibiotic-resistant Pseudomonas Aeruginosa

Overview
Specialty Microbiology
Date 2005 Mar 8
PMID 15750083
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

We describe the molecular characterization of a multiresistant Pseudomonas aeruginosa clone causing an outbreak in the intensive care unit (ICU) of a tertiary-care university hospital. Analysis included antimicrobial susceptibility profile, O-serotyping, pulsed-field gel electrophoresis, and amplified fragment length polymorphism. Resistance mechanisms were characterized, including production of naturally occurring and acquired beta-lactamases, porin expression, and efflux pump systems. Eighteen patients were colonized or infected with multiresistant P. aeruginosa. Multiresistant P. aeruginosa was panresistant to penicillins, cephalosporins, carbapenems, aminoglycosides, and fluoroquinolones and remained susceptible only to colistin. Sixteen isolates (89%) belonged to serotype O:11, pulsed-field gel electrophoresis type A1, and amplified fragment length polymorphism type A. Resistance characterization of this epidemic clone showed an overexpression of the chromosomal cephalosporinase AmpC combined with decreased expression of porin OprD and the absence of metallo-beta-lactamase or extended-spectrum beta-lactamase. An upregulation of the MexXY efflux system due to an agrZ mutation in the mexZ repressor was detected. This epidemic clone was restricted to the ICU and was not found elsewhere in hospital. Contamination of the ICU environment and the hands of an ICU nurse with this clone suggests possible hand-borne transmission. Implementation of contact precautions effectively controlled transmission of the epidemic clone. This study illustrates the ability of multiresistant P. aeruginosa to cause an outbreak with significant morbidity and mortality and underscores the need to identify clonal outbreaks, which require targeted infection control measures.

Citing Articles

Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health.

Li T, Wang Z, Guo J, de la Fuente-Nunez C, Wang J, Han B Sci Total Environ. 2022; 860:160461.

PMID: 36435256 PMC: 11537282. DOI: 10.1016/j.scitotenv.2022.160461.


New Variants of Pseudomonas High-Risk Clone ST233 Associated with an Outbreak in a Mexican Paediatric Hospital.

Aguilar-Rodea P, Estrada-Javier E, Jimenez-Rojas V, Gomez-Ramirez U, Nolasco-Romero C, Rodea G Microorganisms. 2022; 10(8).

PMID: 36013951 PMC: 9414371. DOI: 10.3390/microorganisms10081533.


Ecthyma gangrenosum as a serious complication of infection in departments of paediatric oncology.

Galazka P, Kaczor P, Kaluzny K, Leis K Postepy Dermatol Alergol. 2021; 38(4):537-543.

PMID: 34658690 PMC: 8501443. DOI: 10.5114/ada.2020.100747.


Efflux -Mediated Resistance in Isolated from Patients with Healthcare Associated Infections.

Kishk R, Abdalla M, Hashish A, Nemr N, El Nahhas N, Alkahtani S Pathogens. 2020; 9(6).

PMID: 32549303 PMC: 7350317. DOI: 10.3390/pathogens9060471.


The prevalence of and multidrug resistant in healthy captive ophidian.

Sala A, Di Ianni F, Pelizzone I, Bertocchi M, Santospirito D, Rogato F PeerJ. 2019; 7:e6706.

PMID: 30997288 PMC: 6463849. DOI: 10.7717/peerj.6706.


References
1.
Struelens M, Rost F, Deplano A, Maas A, Schwam V, Serruys E . Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med. 1993; 95(5):489-98. DOI: 10.1016/0002-9343(93)90331-i. View

2.
Grundmann H, Kropec A, Hartung D, Berner R, Daschner F . Pseudomonas aeruginosa in a neonatal intensive care unit: reservoirs and ecology of the nosocomial pathogen. J Infect Dis. 1993; 168(4):943-7. DOI: 10.1093/infdis/168.4.943. View

3.
Vincent J, Bihari D, Suter P, Bruining H, White J, Wolff M . The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995; 274(8):639-44. View

4.
Talon D, Cailleaux V, Thouverez M, Michel-Briand Y . Discriminatory power and usefulness of pulsed-field gel electrophoresis in epidemiological studies of Pseudomonas aeruginosa. J Hosp Infect. 1996; 32(2):135-45. DOI: 10.1016/s0195-6701(96)90055-9. View

5.
Tassios P, Gennimata V, Maniatis A, Fock C, Legakis N . Emergence of multidrug resistance in ubiquitous and dominant Pseudomonas aeruginosa serogroup O:11. The Greek Pseudomonas Aeruginosa Study Group. J Clin Microbiol. 1998; 36(4):897-901. PMC: 104657. DOI: 10.1128/JCM.36.4.897-901.1998. View